Correction: The Efficacy, Safety, and Efficiency of the Off-Label Use of Bevacizumab in Patients Diagnosed With Age-Related Macular Degeneration: Protocol for a Systematic Review and Meta-Analysis

Detalles Bibliográficos
Autores principales: Estarreja, João, Mendes, Priscila, Silva, Carina, Camacho, Pedro, Mateus, Vanessa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2023
Materias:
Corrigenda and Addenda
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10354650/
https://www.ncbi.nlm.nih.gov/pubmed/37402312
http://dx.doi.org/10.2196/50411
_version_ 1785074972779085824
author Estarreja, João
Mendes, Priscila
Silva, Carina
Camacho, Pedro
Mateus, Vanessa
author_facet Estarreja, João
Mendes, Priscila
Silva, Carina
Camacho, Pedro
Mateus, Vanessa
author_sort Estarreja, João
collection PubMed
description
format Online
Article
Text
id pubmed-10354650
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher JMIR Publications
record_format MEDLINE/PubMed
spelling pubmed-103546502023-07-20 Correction: The Efficacy, Safety, and Efficiency of the Off-Label Use of Bevacizumab in Patients Diagnosed With Age-Related Macular Degeneration: Protocol for a Systematic Review and Meta-Analysis Estarreja, João Mendes, Priscila Silva, Carina Camacho, Pedro Mateus, Vanessa JMIR Res Protoc Corrigenda and Addenda JMIR Publications 2023-07-04 /pmc/articles/PMC10354650/ /pubmed/37402312 http://dx.doi.org/10.2196/50411 Text en ©João Estarreja, Priscila Mendes, Carina Silva, Pedro Camacho, Vanessa Mateus. Originally published in JMIR Research Protocols (https://www.researchprotocols.org), 04.07.2023. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Research Protocols, is properly cited. The complete bibliographic information, a link to the original publication on https://www.researchprotocols.org, as well as this copyright and license information must be included.
spellingShingle Corrigenda and Addenda
Estarreja, João
Mendes, Priscila
Silva, Carina
Camacho, Pedro
Mateus, Vanessa
Correction: The Efficacy, Safety, and Efficiency of the Off-Label Use of Bevacizumab in Patients Diagnosed With Age-Related Macular Degeneration: Protocol for a Systematic Review and Meta-Analysis
title Correction: The Efficacy, Safety, and Efficiency of the Off-Label Use of Bevacizumab in Patients Diagnosed With Age-Related Macular Degeneration: Protocol for a Systematic Review and Meta-Analysis
title_full Correction: The Efficacy, Safety, and Efficiency of the Off-Label Use of Bevacizumab in Patients Diagnosed With Age-Related Macular Degeneration: Protocol for a Systematic Review and Meta-Analysis
title_fullStr Correction: The Efficacy, Safety, and Efficiency of the Off-Label Use of Bevacizumab in Patients Diagnosed With Age-Related Macular Degeneration: Protocol for a Systematic Review and Meta-Analysis
title_full_unstemmed Correction: The Efficacy, Safety, and Efficiency of the Off-Label Use of Bevacizumab in Patients Diagnosed With Age-Related Macular Degeneration: Protocol for a Systematic Review and Meta-Analysis
title_short Correction: The Efficacy, Safety, and Efficiency of the Off-Label Use of Bevacizumab in Patients Diagnosed With Age-Related Macular Degeneration: Protocol for a Systematic Review and Meta-Analysis
title_sort correction: the efficacy, safety, and efficiency of the off-label use of bevacizumab in patients diagnosed with age-related macular degeneration: protocol for a systematic review and meta-analysis
topic Corrigenda and Addenda
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10354650/
https://www.ncbi.nlm.nih.gov/pubmed/37402312
http://dx.doi.org/10.2196/50411
work_keys_str_mv AT estarrejajoao correctiontheefficacysafetyandefficiencyoftheofflabeluseofbevacizumabinpatientsdiagnosedwithagerelatedmaculardegenerationprotocolforasystematicreviewandmetaanalysis
AT mendespriscila correctiontheefficacysafetyandefficiencyoftheofflabeluseofbevacizumabinpatientsdiagnosedwithagerelatedmaculardegenerationprotocolforasystematicreviewandmetaanalysis
AT silvacarina correctiontheefficacysafetyandefficiencyoftheofflabeluseofbevacizumabinpatientsdiagnosedwithagerelatedmaculardegenerationprotocolforasystematicreviewandmetaanalysis
AT camachopedro correctiontheefficacysafetyandefficiencyoftheofflabeluseofbevacizumabinpatientsdiagnosedwithagerelatedmaculardegenerationprotocolforasystematicreviewandmetaanalysis
AT mateusvanessa correctiontheefficacysafetyandefficiencyoftheofflabeluseofbevacizumabinpatientsdiagnosedwithagerelatedmaculardegenerationprotocolforasystematicreviewandmetaanalysis

Ejemplares similares